Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00324064 · ClinicalTrials.gov registry record · NA
Sexually Dimorphic Effects of GHRH in Adult Growth Hormone Testing
A NA study, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT00324064 is a NA study that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 90 participants.
The verdict
NCT00324064, a NA study, has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
Specific Aim 1 Healthy male and female subjects and growth hormone (GH) deficient subjects display sexually dimorphic GH responses to GHRH administration Specific Aim 2 GH responses to GHRH in both healthy controls and in GH deficient patients correlate with expression and activity of the stimulatory G proteins, G alpha q and G alpha S. G protein levels correlate with gonadal steroid levels. Specific Aim 3 Sexually dimorphic GH responses to GHRH are enhanced in Tanner Stage V compared to Tanner Stage 1 individuals
Interventions
- PROCEDURE GHRH/arginine stimulation testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2007-07 |
| Est. Completion | 2009-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00324064
The ClinicalTrials.gov registry entry for NCT00324064 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Mercy Hospital Kansas City, which has 184 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GHRH/arginine stimulation testing is the first listed.
NCT00324064 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00324064 about?
NCT00324064 is a clinical study titled "Sexually Dimorphic Effects of GHRH in Adult Growth Hormone Testing". Specific Aim 1 Healthy male and female subjects and growth hormone (GH) deficient subjects display sexually dimorphic GH responses to GHRH administration Specific Aim 2 GH responses to GHRH in both healthy controls and in GH deficient patients correlate with expression and activity of the stimulato...
What is the current status of trial NCT00324064?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2007-07. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00324064?
The interventions under investigation include: GHRH/arginine stimulation testing (PROCEDURE).
Who is sponsoring clinical trial NCT00324064?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.